Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
45.7M
-
Shares change
-
-1.18M
-
Total reported value, excl. options
-
$454M
-
Value change
-
-$5.08M
-
Put/Call ratio
-
0.56
-
Number of buys
-
79
-
Number of sells
-
-69
-
Price
-
$9.94
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2019
207 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q1 2019.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.7M shares
of 112M outstanding shares and own 40.72% of the company stock.
Largest 10 shareholders include STATE STREET CORP (7.23M shares), ArrowMark Colorado Holdings LLC (4.5M shares), BlackRock Inc. (4.11M shares), VANGUARD GROUP INC (3.11M shares), FMR LLC (3.07M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.76M shares), Park West Asset Management LLC (1.57M shares), Fiera Capital Corp (1.42M shares), CITADEL ADVISORS LLC (1.07M shares), and BANK OF AMERICA CORP /DE/ (900K shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.